- Home
- ETNB vs WINA Comparison
ETNB vs WINA Comparison
Compare ETNB & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- WINA
- Stock Information
- Founded
- ETNB 2018
- WINA 1988
- Country
- ETNB United States
- WINA United States
- Employees
- ETNB N/A
- WINA N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- WINA Other Specialty Stores
- Sector
- ETNB Health Care
- WINA Consumer Discretionary
- Exchange
- ETNB Nasdaq
- WINA Nasdaq
- Market Cap
- ETNB 1.5B
- WINA 1.3B
- IPO Year
- ETNB 2019
- WINA 1993
- Fundamental
- Price
- ETNB $10.12
- WINA $374.38
- Analyst Decision
- ETNB Strong Buy
- WINA
- Analyst Count
- ETNB 8
- WINA 0
- Target Price
- ETNB $26.43
- WINA N/A
- AVG Volume (30 Days)
- ETNB 2.2M
- WINA 296.4K
- Earning Date
- ETNB 08-04-2025
- WINA 07-16-2025
- Dividend Yield
- ETNB N/A
- WINA 2.96%
- EPS Growth
- ETNB N/A
- WINA 2.14
- EPS
- ETNB N/A
- WINA 11.19
- Revenue
- ETNB N/A
- WINA $83,099,300.00
- Revenue This Year
- ETNB N/A
- WINA $6.56
- Revenue Next Year
- ETNB N/A
- WINA $3.57
- P/E Ratio
- ETNB N/A
- WINA $33.46
- Revenue Growth
- ETNB N/A
- WINA 0.33
- 52 Week Low
- ETNB $4.16
- WINA $295.79
- 52 Week High
- ETNB $11.84
- WINA $459.93
- Technical
- Relative Strength Index (RSI)
- ETNB 58.34
- WINA 36.81
- Support Level
- ETNB $9.45
- WINA $362.39
- Resistance Level
- ETNB $10.34
- WINA $389.20
- Average True Range (ATR)
- ETNB 0.52
- WINA 18.74
- MACD
- ETNB -0.07
- WINA -6.38
- Stochastic Oscillator
- ETNB 69.34
- WINA 12.29
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.